4//SEC Filing
Rolke James 4
Accession 0001209191-23-013629
CIK 0001810560other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:08 PM ET
Size
5.6 KB
Accession
0001209191-23-013629
Insider Transaction Report
Form 4
Rolke James
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-25+2,542→ 0 totalExercise: $49.00Exp: 2032-02-25→ Common Stock (2,542 underlying)
Footnotes (1)
- [F1]The stock options were granted on 2/25/2022 and vest 25% on the one-year anniversary of the grant date, and thereafter quarterly over a three-year period, subject to continued service through each such vesting date.
Documents
Issuer
REVELATION BIOSCIENCES, INC.
CIK 0001810560
Entity typeother
Related Parties
1- filerCIK 0001693858
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:08 PM ET
- Size
- 5.6 KB